<?xml version="1.0" encoding="utf-8"?>
<doi_batch xmlns="http://www.crossref.org/schema/4.3.6" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" xmlns:fr="http://www.crossref.org/fundref.xsd" version="4.3.6" xsi:schemaLocation="http://www.crossref.org/schema/4.3.6 https://www.crossref.org/schemas/crossref4.3.6.xsd">
  <head>
    <doi_batch_id>_1757918440</doi_batch_id>
    <timestamp>20250915064040000</timestamp>
    <depositor>
      <depositor_name>Editor</depositor_name>
      <email_address>editor.jddt@gmail.com</email_address>
    </depositor>
    <registrant>Universal Journal of Pharmaceutical Research</registrant>
  </head>
  <body>
    <journal>
      <journal_metadata>
        <full_title>Universal Journal of Pharmaceutical Research</full_title>
        <abbrev_title>Univ J Pharm Res</abbrev_title>
        <issn media_type="electronic">2456-8058</issn>
        <issn media_type="print">2831-5235</issn>
      </journal_metadata>
      <journal_issue>
        <publication_date media_type="online">
          <month>09</month>
          <day>15</day>
          <year>2025</year>
        </publication_date>
      </journal_issue>
      <journal_article xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" publication_type="full_text" metadata_distribution_opts="any">
        <titles>
          <title>FORMULATION AND EVALUATION OF TINIDAZOLE ENTERIC COATED TABLETS FOR COLON TARGETING DRUG DELIVERY SYSTEM</title>
        </titles>
        <contributors>
          <person_name contributor_role="author" sequence="first">
            <surname>Fatehalrahman F. Magbool</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Elamin Ibrahim Elnima</surname>
          </person_name>
          <person_name contributor_role="author" sequence="additional">
            <surname>Shayoub M. E.</surname>
          </person_name>
        </contributors>
        <jats:abstract xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1">
          <jats:p>Aim and Objective: Colon-specific delivery systems have garnered significant attention for their capacity to localize therapy within the large intestine, thereby enhancing treatment efficacy for colonic disorders and reducing systemic toxicity.
Methods: Core tablets containing tinidazole were prepared using a variety of polymers in distinct ratios, followed by application of an enteric coating. Pre-compression evaluation included assessment of powder flow characteristics and compatibility checks between the drug and excipients via FT-IR spectroscopy, with all batches demonstrating no evidence of interaction. Post-compression, tablets were tested for weight uniformity, mechanical strength, friability, and content uniformity, alongside in vitro dissolution studies under conditions simulating gastrointestinal transit.
Results: All formulations exhibited acceptable chemical and physical properties, with assay values ranging from 98.44 % to 99.89 %, indicating consistent drug loading across batches F1 through F5. The F5 batch emerged as the optimal candidate, sustaining tinidazole release for six hours and achieving a cumulative release of 98.32 %. Stability testing of F5 at 45 °C and 75 % relative humidity over three months revealed no significant changes in performance or integrity. Consequently, formulation F5 is proposed as a robust platform for targeted colonic delivery of tinidazole.
Conclusion: The investigation achieved the formulation of enteric-coated tinidazole tablets optimized for oral delivery and targeted release in the distal gastrointestinal tract.
                   
Peer Review History: 
Received 9 June 2025;   Reviewed 14 July 2025; Accepted 23 August; Available online 15 September 2025
Academic Editor: Dr. DANIYAN Oluwatoyin Michael, Obafemi Awolowo University, ILE-IFE, Nigeria, toyinpharm@gmail.com
Reviewers:
Dr. Ali Awad Allah Ali Moh. Saeed, National University, Sudan, alimhsd@gmail.com
Ali Jaber,   Laboratory for Research and Development of Medicines and Natural Products, RDMPN, Faculty of Pharmacy, Lebanese University, Beirut, Lebanon, ali.jaber.2@ul.edu.lb</jats:p>
        </jats:abstract>
        <publication_date media_type="online">
          <month>09</month>
          <day>15</day>
          <year>2025</year>
        </publication_date>
        <fr:program name="fundref"/>
        <ai:program xmlns:ai="http://www.crossref.org/AccessIndicators.xsd" name="AccessIndicators">
          <ai:license_ref>http://creativecommons.org/licenses/by-nc/4.0</ai:license_ref>
        </ai:program>
        <doi_data>
          <doi>10.22270/ujpr.v10i4.1391</doi>
          <resource>https://ujpronline.com/index.php/journal/article/view/1391</resource>
          <collection property="crawler-based">
            <item crawler="iParadigms">
              <resource>https://ujpronline.com/index.php/journal/article/download/1391/1942</resource>
            </item>
          </collection>
          <collection property="text-mining">
            <item>
              <resource mime_type="application/pdf">https://ujpronline.com/index.php/journal/article/download/1391/1942</resource>
            </item>
            <item>
              <resource mime_type="text/xml">https://ujpronline.com/index.php/journal/article/download/1391/1956</resource>
            </item>
            <item>
              <resource mime_type="text/html">https://ujpronline.com/index.php/journal/article/download/1391/1972</resource>
            </item>
          </collection>
        </doi_data>
      </journal_article>
    </journal>
  </body>
</doi_batch>
